Tristel - Asset Resilience Ratio

Latest as of December 2025: 13.71%

Tristel (TSTL) has an Asset Resilience Ratio of 13.71% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read how much debt does Tristel carry for a breakdown of total debt and financial obligations.

Liquid Assets

GBX6.23 Million
≈ $758.01 USD Cash + Short-term Investments

Total Assets

GBX45.43 Million
≈ $5.53K USD All company assets

Resilience Assessment

Moderate
Financial Resilience Level

Asset Resilience Ratio Trend (2018–2025)

This chart shows how Tristel's Asset Resilience Ratio has changed over time. See what is Tristel's book value for net asset value and shareholders' equity analysis.

Liquid Assets Composition Over Time

This chart breaks down Tristel's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see how much is Tristel worth.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents GBX0.00 0%
Short-term Investments GBX6.23 Million 13.71%
Total Liquid Assets GBX6.23 Million 13.71%

Asset Resilience Insights

  • Moderate Liquidity: Tristel has 13.71% of assets in liquid form.
  • While adequate for normal operations, this level may limit flexibility during economic stress.
  • The company has significant short-term investments, indicating active treasury management.

Tristel Industry Peers by Asset Resilience Ratio

Compare Tristel's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Caina Technology Co. Ltd.
SHE:301122
Medical Instruments & Supplies 23.52%
Mark Dynamics Indonesia Tbk PT
JK:MARK
Medical Instruments & Supplies 6.64%
GETS Global Bhd
KLSE:5079
Medical Instruments & Supplies 0.03%
QITIAN Technology Group Co Ltd
SHE:300061
Medical Instruments & Supplies 0.00%
Sartorius Aktiengesellschaft
XETRA:SRT3
Medical Instruments & Supplies 4.48%
Anbio Biotechnology Class A Ordinary Shares
NASDAQ:NNNN
Medical Instruments & Supplies 29.19%
Ansell Ltd
AU:ANN
Medical Instruments & Supplies 4.42%
Nanosonics Ltd
AU:NAN
Medical Instruments & Supplies 51.82%

Annual Asset Resilience Ratio for Tristel (2018–2025)

The table below shows the annual Asset Resilience Ratio data for Tristel.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2025-06-30 9.26% GBX4.20 Million
≈ $511.02
GBX45.33 Million
≈ $5.52K
-3.54pp
2024-06-30 12.81% GBX5.65 Million
≈ $687.44
GBX44.11 Million
≈ $5.37K
+6.93pp
2023-06-30 5.88% GBX2.43 Million
≈ $295.90
GBX41.37 Million
≈ $5.03K
-25.02pp
2019-06-30 30.90% GBX8.80 Million
≈ $1.07K
GBX28.49 Million
≈ $3.47K
+33.08pp
2018-06-30 -2.18% GBX-492.00K
≈ $-59.86
GBX22.54 Million
≈ $2.74K
--
pp = percentage points

About Tristel

LSE:TSTL UK Medical Instruments & Supplies
Market Cap
$2.36 Million
GBX19.41 Billion GBX
Market Cap Rank
#29507 Global
#643 in UK
Share Price
GBX405.00
Change (1 day)
+3.32%
52-Week Range
GBX345.00 - GBX440.00
All Time High
GBX617.87
About

Tristel plc develops, manufactures, and sells infection prevention products in the United Kingdom, Australia, Germany, Western Europe, and internationally. The company operates through three segments: Hospital Medical Device Decontamination, Hospital Environmental Surface Disinfection, and Other. It offers device decontamination products, including wipes system, ULT, OPH, Stella system, fuse for … Read more